Cellectar Biosciences GAAP EPS of -$8.35
Source: SeekingAlpha
2026-03-04 07:16:29 ET
More on Cellectar Biosciences
- Seeking Alpha’s Quant Rating on Cellectar Biosciences
- Historical earnings data for Cellectar Biosciences
- Financial information for Cellectar Biosciences
Read the full article on Seeking Alpha
For further details see:
Cellectar Biosciences GAAP EPS of -$8.35
Cellectar Biosciences Inc.
NASDAQ: CLRB
CLRB Trading
-1.47% G/L:
$2.68 Last:
20,755 Volume:
$2.81 Open:
CLRB Latest News
March 04, 2026 07:15:00 am
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
February 25, 2026 08:05:00 am
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
CLRB Stock Data
$14,077,245
4,026,431
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
